|
Ceasing to be a substantial holder
|
23 June 2023 at 4:50pm
|
|
Exclusive Agreement for HIV Testing Signed with Newfoundland
|
14 June 2023 at 10:20am
|
|
Change in substantial holding
|
6 June 2023 at 6:25pm
|
|
Change in substantial holding
|
15 May 2023 at 7:55pm
|
|
Change in substantial holding
|
15 May 2023 at 7:55pm
|
|
Becoming a substantial holder
|
28 April 2023 at 5:35pm
|
|
Investor Webinar Presentation
|
27 April 2023 at 12:50pm
|
|
Quarterly Activity Report - 31 March 2023
|
27 April 2023 at 8:45am
|
|
Appendix 4C - 31 March 2023
|
27 April 2023 at 8:45am
|
|
Notification of cessation of securities - AT1
|
18 April 2023 at 4:30pm
|
|
Change of Director's Interest Notice - J Keith
|
18 April 2023 at 3:35pm
|
|
Change of Director's Interest Notice - C LaBelle
|
18 April 2023 at 3:35pm
|
|
A$1.9m contract - South Africa HIV Self-Test private market
|
5 April 2023 at 9:50am
|
|
Ceasing to be a substantial holder
|
20 March 2023 at 6:35pm
|
|
Significant Purchase Order for HIV Self-Tests for Europe
|
28 February 2023 at 9:20am
|
|
Atomo H1 FY23 Results Presentation
|
23 February 2023 at 8:35am
|
|
Investor Presentation
|
23 February 2023 at 8:35am
|
|
Appendix 4D and Half Year Financial Report
|
23 February 2023 at 8:35am
|
|
Change of Company Secretary
|
22 February 2023 at 1:50pm
|
|
Quarterly Activity Report - 31 December 2022
|
27 January 2023 at 4:50pm
|
|
Appendix 4C - 31 December 2022
|
27 January 2023 at 4:50pm
|
|
Investor Webinar Presentation
|
27 January 2023 at 10:20am
|
|
Agreement for Rapid Pregnancy Tests Signed with NG Biotech
|
18 January 2023 at 9:50am
|
|
Initial Director's Interest Notice - Dr Walker
|
15 November 2022 at 9:25am
|
|
Appointment of Independent Non-Executive Director
|
15 November 2022 at 9:15am
|
|
Investor Webinar and Presentation
|
28 October 2022 at 9:45am
|
|
Change of Director's Interest Notice - John Kelly
|
27 October 2022 at 4:15pm
|
|
Notification regarding unquoted securities - AT1
|
27 October 2022 at 4:10pm
|
|
Results of 2022 Annual General Meeting
|
27 October 2022 at 4:10pm
|
|
2022 Annual General Meeting - MD & CEO's Address
|
27 October 2022 at 9:50am
|
|
2022 Annual General Meeting - Chairman's Address
|
27 October 2022 at 9:45am
|
|
Quarterly Activity Report - 30 September 2022
|
25 October 2022 at 5:25pm
|
|
Appendix 4C - 30 September 2022
|
25 October 2022 at 5:25pm
|
|
2022 Annual Report
|
23 September 2022 at 10:20am
|
|
2022 Notice of Annual General Meeting
|
23 September 2022 at 8:55am
|
|
Atomo FY22 Results Presentation
|
7 September 2022 at 10:15am
|
|
Change of Director's Interest Notice - John Kelly
|
2 September 2022 at 9:50am
|
|
Notification regarding unquoted securities - AT1
|
2 September 2022 at 9:50am
|
|
Notification of cessation of securities - AT1
|
2 September 2022 at 9:50am
|
|
2022 Appendix 4G and Corporate Governance Statement
|
25 August 2022 at 6:55pm
|
|
Investor Webinar and Presentation
|
25 August 2022 at 6:10pm
|
|
2022 Appendix 4E and Annual Report
|
25 August 2022 at 5:50pm
|
|
COVID RAT Supply Agreement signed with AllTest & TGA Update
|
22 August 2022 at 5:40pm
|
|
Quarterly Activity Report - 30 June 2022
|
29 July 2022 at 8:59am
|
|
Appendix 4C - 30 June 2022
|
29 July 2022 at 8:50am
|
|
Change in substantial holding
|
14 July 2022 at 7:15pm
|
|
Change in substantial holding
|
27 May 2022 at 6:25pm
|
|
Cleansing Statement
|
6 May 2022 at 9:35am
|
|
Application for quotation of securities - AT1
|
3 May 2022 at 4:50pm
|
|
Notification regarding unquoted securities - AT1
|
29 April 2022 at 5:50pm
|
